Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Research & Drug Development

2006

Present and future approaches to Parkinson's disease: From molecular insights to new therapeutic avenues

R. Fariello et al.

Neurology, 10 October 2006  Volume 67,7, (Suppl 2): SS1 - S38